Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Apple
AAPL
|
$1.64B |
| 2 |
Microsoft
MSFT
|
$1.2B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.04B |
| 4 |
HCA Healthcare
HCA
|
$754M |
| 5 |
American Express
AXP
|
$731M |
Top Sells
| 1 |
Amgen
AMGN
|
$7.23B |
| 2 |
Wells Fargo
WFC
|
$5.61B |
| 3 |
Becton Dickinson
BDX
|
$4.1B |
| 4 |
Tesla
TSLA
|
$3.17B |
| 5 |
Qualcomm
QCOM
|
$1.38B |
Sector Composition
| 1 | Technology | 19.87% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 15.27% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Communication Services | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Thermo Fisher Scientific
TMO
$186B
| $1.59B | 0.18% |
6,499,139
+1,016,082
| +19% | +$248M |
|
102
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.57B | 0.18% |
5,417,471
+6,731
| +0.1% | +$1.96M |
|
103
General Dynamics
GD
$87.3B
| $1.57B | 0.18% |
7,674,090
-50,839
| -0.7% | -$10.4M |
|
104
Synchrony
SYF
$28.4B
| $1.56B | 0.18% |
50,346,639
+563,203
| +1% | +$17.5M |
|
105
Marriott International Class A Common Stock
MAR
$72.7B
| $1.55B | 0.17% |
11,750,984
-3,290,019
| -22% | -$434M |
|
106
Biogen
BIIB
$19.4B
| $1.53B | 0.17% |
4,322,187
-1,025,928
| -19% | -$362M |
|
107
Morgan Stanley
MS
$240B
| $1.52B | 0.17% |
32,690,082
-13,126,956
| -29% | -$611M |
|
|
108
HCA Healthcare
HCA
$94.5B
| $1.52B | 0.17% |
10,907,407
+5,419,134
| +99% | +$754M |
|
109
American International
AIG
$45.1B
| $1.51B | 0.17% |
28,305,780
+5,684,245
| +25% | +$303M |
|
110
CSX Corp
CSX
$60.6B
| $1.5B | 0.17% |
20,293,872
-1,548,828
| -7% | -$115M |
|
111
Travelers Companies
TRV
$61.1B
| $1.5B | 0.17% |
11,564,286
-367,277
| -3% | -$47.6M |
|
112
British American Tobacco
BTI
$124B
| $1.5B | 0.17% |
32,095,177
-671,488
| -2% | -$31.3M |
|
113
Norfolk Southern
NSC
$62.8B
| $1.46B | 0.16% |
8,080,231
+1,043,444
| +15% | +$188M |
|
114
Nektar Therapeutics
NKTR
$568M
| $1.46B | 0.16% |
23,919,566
-1,786,336
| -7% | -$109M |
|
115
Philip Morris
PM
$260B
| $1.45B | 0.16% |
17,774,120
-1,074,200
| -6% | -$87.6M |
|
116
PPL Corp
PPL
$27B
| $1.43B | 0.16% |
48,751,387
+1,474,816
| +3% | +$43.2M |
|
117
MSCI
MSCI
$43.9B
| $1.42B | 0.16% |
8,032,189
-682,676
| -8% | -$121M |
|
118
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $1.42B | 0.16% |
16,319,260
-238,752
| -1% | -$20.8M |
|
119
Gilead Sciences
GILD
$140B
| $1.41B | 0.16% |
18,210,622
-1,376,432
| -7% | -$106M |
|
120
AT&T
T
$209B
| $1.41B | 0.16% |
41,855,964
-2,620,851
| -6% | -$88M |
|
121
AstraZeneca
AZN
$248B
| $1.4B | 0.16% |
35,325,790
+15,082,609
| +75% | +$597M |
|
122
Nike
NKE
$114B
| $1.4B | 0.16% |
16,479,696
+818,695
| +5% | +$69.4M |
|
123
T-Mobile US
TMUS
$284B
| $1.38B | 0.16% |
19,644,093
+462,053
| +2% | +$32.4M |
|
124
PTC
PTC
$25.6B
| $1.38B | 0.16% |
12,970,601
-1,384
| -0% | -$147K |
|
|
RTN
125
DELISTED
Raytheon Company
RTN
| $1.37B | 0.15% |
6,626,729
-1,615,601
| -20% | -$334M |
|